<p>(a) Release profiles of piroxicam from microcapsules P1 and P2 in SGF. (b) Release profile of piroxicam from microcapsule P3 in SGF for 5 h followed by release into SIF at 37°C. The insets are the close-up views of the release within first 60 min in SGF.</p
<p>Miltefosine release from selected lipid nanocapsule formulations in PBS pH 7.4 at 37°C over a 24 ...
<p>The release of SR101 (%) from microcapsules (1.4×10<sup>−3</sup> mol TDI) exposed to simulated me...
A common way to formulate controlled-release (CR) pharmaceuticals is to coat pellets of active subst...
<p>(a) Release profiles of fenofibrate from microcapsules F2 and F3 in SGF. (b) Release profiles of ...
<div><p>Floating dosage forms with prolonged gastric residence time have garnered much interest in t...
Floating dosage forms with prolonged gastric residence time have garnered much interest in the field...
A floating type dosage form (FDF) of piroxicam in hollow polycarbonate (PC) microspheres capable of ...
<p>Piroxicam was incorporated into both the outer PEG and inner PCL coating layers. The hollow cavit...
The present investigation of Piroxicam delayed release tablets, many research studies have completed...
Recent advances in floating drug delivery systems (FDDS) have been developed to increase drug bioava...
<p>In vitro release profiles of metformin and ciprofloxacin in simulated gastric solution.</p
A gastro-retentive delivery system loaded with piroxicam with a bimodal release profile in gastroint...
Microcapsules are used especially to obtain sustained release dosage forms but also they are widely ...
The production and physicochemical characterisation of spray chilled Gelucire 50/13 microspheres is ...
Floating polymeric microcapsules that simultaneously entrap multiple drugs were prepared using a sol...
<p>Miltefosine release from selected lipid nanocapsule formulations in PBS pH 7.4 at 37°C over a 24 ...
<p>The release of SR101 (%) from microcapsules (1.4×10<sup>−3</sup> mol TDI) exposed to simulated me...
A common way to formulate controlled-release (CR) pharmaceuticals is to coat pellets of active subst...
<p>(a) Release profiles of fenofibrate from microcapsules F2 and F3 in SGF. (b) Release profiles of ...
<div><p>Floating dosage forms with prolonged gastric residence time have garnered much interest in t...
Floating dosage forms with prolonged gastric residence time have garnered much interest in the field...
A floating type dosage form (FDF) of piroxicam in hollow polycarbonate (PC) microspheres capable of ...
<p>Piroxicam was incorporated into both the outer PEG and inner PCL coating layers. The hollow cavit...
The present investigation of Piroxicam delayed release tablets, many research studies have completed...
Recent advances in floating drug delivery systems (FDDS) have been developed to increase drug bioava...
<p>In vitro release profiles of metformin and ciprofloxacin in simulated gastric solution.</p
A gastro-retentive delivery system loaded with piroxicam with a bimodal release profile in gastroint...
Microcapsules are used especially to obtain sustained release dosage forms but also they are widely ...
The production and physicochemical characterisation of spray chilled Gelucire 50/13 microspheres is ...
Floating polymeric microcapsules that simultaneously entrap multiple drugs were prepared using a sol...
<p>Miltefosine release from selected lipid nanocapsule formulations in PBS pH 7.4 at 37°C over a 24 ...
<p>The release of SR101 (%) from microcapsules (1.4×10<sup>−3</sup> mol TDI) exposed to simulated me...
A common way to formulate controlled-release (CR) pharmaceuticals is to coat pellets of active subst...
DOI
Add to ORKG